Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Operating Leases: 2017-2025

Historic Operating Leases for AC Immune (ACIU) over the last 8 years, with Sep 2025 value amounting to $4.5 million.

  • AC Immune's Operating Leases rose 63.93% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 63.93%. This contributed to the annual value of $4.5 million for FY2025, which is N/A change from last year.
  • Per AC Immune's latest filing, its Operating Leases stood at $4.5 million for FY2025, which was up 89,876.41% from $5,024 recorded in FY2024.
  • AC Immune's 5-year Operating Leases high stood at $4.5 million for FY2025, and its period low was $3,185 during FY2023.
  • Moreover, its 3-year median value for Operating Leases was $5,024 (2024), whereas its average is $1.5 million.
  • Per our database at Business Quant, AC Immune's Operating Leases crashed by 99.86% in 2023 and then surged by 57.75% in 2024.
  • Yearly analysis of 5 years shows AC Immune's Operating Leases stood at $2.6 million in 2021, then fell by 8.67% to $2.3 million in 2022, then slumped by 99.86% to $3,185 in 2023, then surged by 57.75% to $5,024 in 2024, then reached $4.5 million in 2025.